A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

NCT00391196 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

975

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Obesity

Interventions

DRUG: Placebo
DRUG: CP-945,598
DRUG: CP-945,598 Treatment B

Sponsor

Pfizer